Press ReleasesMay 6, 20265 min read

Predictive Analytics For Disease Diagnostics Market is expected to reach USD 12.5 billion by 2031

The market for predictive analytics for disease diagnostics is growing fast because the healthcare industry is moving towards the use of AI and data-based insights for early detection and preventive care. These technologies, which analyze clinical, genomic, and patient data, help in early identification of diseases and in making better treatment decisions. Large companies such as IBM, Oracle Health, SAS Institute, and Siemens Healthineers are leading these technologies.
Predictive Analytics For Disease Diagnostics Market is expected to reach USD 12.5 billion by 2031

Predictive Analytics for Disease Diagnostic Market Trends & Forecast

According to a research study published by Knowledge Sourcing Intelligence (KSI), the predictive analytics for disease diagnostics market will expand from USD 4.5 billion in 2026 to USD 12.5 billion in 2031 at a CAGR of 22.7% during the forecast period.

The predictive analytics for disease diagnostics market is gaining traction mainly because artificial intelligence (AI), machine learning (ML), and big data analytics are being rapidly implemented in clinical decision-making and diagnostic workflows. Healthcare systems worldwide are not only reacting to diseases but also proactively preventing them. In this shift, predictive analytics plays a major role in early identification of diseases, risk assessment, and planning of treatments that are tailored to the individual. With the use of extensive datasets from electronic health records (EHRs), genomics, imaging, and wearable devices, predictive models can recognize patterns linked to major diseases such as cancer, heart diseases, and diabetes, sometimes even before the patients show any symptoms. The ability to do this is very helpful in minimizing hospital readmissions, cutting down healthcare expenses, and enhancing patient care.

Request a free sample copy or view the report summary: Predictive Analytics for Disease Diagnostics Market Report

Predictive Analytics for Disease Diagnostic Market Report Highlights

  • Software is the fastest-growing component within the predictive analytics for disease diagnostics market. The growth is primarily attributable to rising adoption of AI-powered diagnostic algorithms and clinical decision support systems. Healthcare professionals mainly focus on software solutions that are not only customizable but also capable of working together with electronic health records and imaging systems to provide predictive insights in real-time. Besides, the move to cloud-based platforms and subscription models is speeding up the process of adoption, as hospitals and diagnostic centers are looking for economical and always-updated analytics solutions.

  • Deep learning is the fastest-growing segment in technology, especially because of its ability to efficiently process and analyse complex healthcare data, including medical images, genomics, and pathological slides. Neural network-based deep learning models are being adopted for early detection of diseases, cancer classification, and recognition of patterns that were once very challenging to automate. Their capacity to learn and get better over time by working on large datasets leads to an improvement in the accuracy of diagnosis and predictions.

  • Among applications, oncology is the fastest-growing sector, driven mainly by the increasing number of cancer cases worldwide and the critical demand for early cancer detection and individualized therapies. Predictive analytics is an indispensable tool in cancer diagnosis for detecting gene mutations, forecasting disease development, and recommending the best treatment plans. Combining data from multi-omics, imaging, and patient history leads to more accurate and tailored treatment in cancer care.

  • The Asia-Pacific region is the fastest-growing market for Predictive Analytics in Disease Diagnostics, driven by rapid healthcare digitalization, increasing investments in AI-driven healthcare infrastructure, and a large, diverse patient population.

Predictive Analytics for Disease Diagnostic Market Growth Drivers and Restraints

Growth Drivers:

  • Rising Demand for Early Disease Detection and Preventive Healthcare: Worldwide healthcare systems are moving away from reactive treatment towards preventive care. Using predictive analytics, it is possible to detect the risk of diseases in an early stage, which leads to interventions in time to decrease the number of deaths and the cost of treatments. The impact is the greatest in cases of chronic diseases like cancer, heart diseases, and diabetes, where early detection is critical in significantly changing the result for the better. The total number of people with diabetes is forecast to escalate to approximately 853 million by 2050. This tremendous increase will be the result of changing lifestyles, an aging population, and urbanization that will impact health worldwide.

  • Rapid Advancements in AI and Machine Learning Technologies: The development of AI, machine learning, and deep learning algorithms has greatly changed the way predictive models are created. Due to their ability to analyse big and complicated sets of data, such as images, genomics, and clinical records, these technologies have managed to improve the accuracy of diagnostics and have led to the development of personalized treatment strategies.

Restraints:

  • Data Privacy and Security Concerns: Healthcare data contain a high sensitivity level, while the use of predictive analytical methods poses risks regarding breaches, misuse of personal information, and ensuring compliance with the law. Therefore, many strict data protection laws could hinder healthcare organizations from sharing their data freely and impede the speed at which predictive solutions can be implemented.

Predictive Analytics for the Disease Diagnostic Market Key Development

  • Product Launch: In June 2025, IBM and Roche made a joint announcement about their partnership, which led to the creation of an AI-powered predictive glucose monitoring tool to help diabetes patients manage their condition effectively.

  • Product Launch: In February 2025, DeepHealth, Inc., a leading company in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc., showcased its latest AI-driven radiology informatics and population screening solutions at the European Congress of Radiology (ECR) 2025 in Vienna.

Predictive Analytics for Disease Diagnostic Market Segmentation

Knowledge Sourcing Intelligence has segmented the predictive analytics for the disease diagnostic market based on component, technology, application, and region:

Predictive Analytics for Disease Diagnostic Market, By Component

  • Software

  • Data Management Platforms

  • Services

Predictive Analytics for Disease Diagnostic Market, By Technology

  • Machine Learning

  • Deep Learning

  • Data Mining

  • Natural Language Processing

Predictive Analytics for Disease Diagnostic Market, By Application

  • Oncology

  • Cardiology

  • Neurology

  • Infectious Diseases

  • Chronic Disease Management

Predictive Analytics for Disease Diagnostic Market, By Region

  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • United Kingdom

    • Germany

    • France

    • Spain

    • Others

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Indonesia

    • Thailand

    • Others

  • South America

    • Brazil

    • Argentina

    • Others

  • Middle East and Africa (MEA)

    • Saudi Arabia

    • UAE

    • Others

Predictive Analytics for Disease Diagnostic Market Key Players

  • IBM

  • Oracle Health

  • SAS Institute

  • Cerner Corporation

  • Epic Systems

  • Siemens Healthineers

  • Philips Healthcare

  • Tempus

  • Flatiron Health

  • Palantir Technologies